1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Prohance: new trials by email Literature Review of Prohance trials Research Report on Prohance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain gadoteridol, gadobutrol - Brain Disease | Phase 4 | Completed | Bracco Diagnostics, Inc | 229 | 2012-08-01 | 2015-07-01 |
Brain Diseases (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Neuroendocrine Tumors (1) · Prostatic Neoplasms (1)
Bracco Diagnostics, Inc (1) · Guerbet (1)
United States (2) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Russia (1) · South Korea (1)